7 completed. 4 Phase 3, 2 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Meningitec: new trials by email Literature Review of Meningitec trials Research Report on Meningitec
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children PriorixTetra™, Meningitec - Rubella, Varicella | Phase 3 | Completed | GlaxoSmithKline | 716 | 2012-02-06 | 2018-08-17 |
| Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children Meningococcal vaccine GSK134612 (Nimenrix), Priorix-Tetra, Meningitec - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 1000 | 2007-06-05 | 2019-11-18 |
| Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Infanrix hexa - Hepatitis B, Acellular Pertussis | Phase 3 | Completed | GlaxoSmithKline | 1437 | 2007-04-25 | 2020-01-02 |
| Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m Tritanrix-HepB/Hib-MenAC, Mencevax ACWY, Tritanrix-HepB/Hiberix - Whole Cell Pertussis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 617 | 2006-01-22 | 2020-02-20 |
| Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time Prevenar and Meningitec, Prevenar, Meningitec - Healthy | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 712 | 2006-01-01 | 2007-12-27 |
| Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine Conjugated meningococcal ACWY-TT (vaccine), DTPa/Hib containing vaccine, Meningitec - Infections, Meningococcal | Phase 2 | Completed | GlaxoSmithKline | 508 | 2005-07-01 | 2016-10-07 |
| Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis tacrolimus ointment 0.03%, hydrocortisone acetate ointment 1%, hydrocortisone butyrate ointment 0.1% - Atopic Dermatitis | Phase 2 | Completed | Astellas Pharma Inc | 260 | 2003-03-01 | 2014-09-18 |
Meningococcal Infections (4) · Diphtheria (2) · Hepatitis B (2) · Meningitis (2) · Pneumococcal Infections (2) · Tetanus (2) · Chickenpox (1) · Dermatitis, Atopic (1) · Fever (1) · Haemophilus Infections (1) · Measles (1) · Mumps (1) · Poliomyelitis (1) · Rubella (1)
GlaxoSmithKline (5) · Astellas Pharma Inc (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
Germany (3) · Poland (2) · Australia (1) · Austria (1) · Belgium (1) · Finland (1) · Hungary (1) · Iceland (1) · Italy (1) · Malta (1) · Portugal (1) · Spain (1) · Thailand (1)